Identification of potential targets of the curcumin analog CCA-1.1 for glioblastoma treatment: integrated computational analysis and in vitro study

A Hermawan, F Wulandari, N Hanif, RY Utomo… - Scientific Reports, 2022 - nature.com
The treatment of glioblastoma multiforme (GBM) is challenging owing to its localization in the
brain, the limited capacity of brain cells to repair, resistance to conventional therapy, and its …

Preparation and cytotoxic evaluation of PGV-1 derivative, CCA-1.1, as a new curcumin analog with improved-physicochemical and pharmacological properties

RY Utomo, F Wulandari, D Novitasari… - Advanced …, 2021 - pmc.ncbi.nlm.nih.gov
Purpose: This study aimed to challenge the anticancer potency of pentagamavunone-1
(PGV-1) and obtain a new compound (Chemoprevention-Curcumin Analog 1.1, CCA-1.1) …

[HTML][HTML] CCA-1.1, a novel curcumin analog, exerts cytotoxic anti-migratory activity toward TNBC and HER2-enriched breast cancer cells

D Novitasari, RI Jenie, RY Utomo, J Kato… - Asian Pacific Journal …, 2021 - ncbi.nlm.nih.gov
Objective: Chemoprevention curcumin Analog-1.1 (CCA-1.1) demonstrates antineoplastic
effect toward cancer cells. By using triple-negative breast cancer (TNBC), 4T1, and human …

[HTML][HTML] Cytoprotective properties of citronella oil (Cymbopogon nardus (L.) Rendl.) and lemongrass oil (Cymbopogon citratus (DC.) Stapf) through attenuation of …

DU Salsabila, RK Wardani, NU Hasanah… - Asian Pacific Journal …, 2023 - ncbi.nlm.nih.gov
Objective: This study aimed to determine the cytoprotective potentials of citronella
(Cymbopogon nardus (L.) Rendl.) essential oil (CO) and lemongrass (Cymbopogon citratus …

[HTML][HTML] Piperine increases pentagamavunon-1 anti-cancer activity on 4T1 breast cancer through mitotic catastrophe mechanism and senescence with sharing …

E Endah, F Wulandari, Y Putri, RI Jenie… - Iranian Journal of …, 2022 - ncbi.nlm.nih.gov
Pentagamavunon-1 performs more potent anti-cancer effects than curcumin against various
cancer cells, but it remains to be optimized. Piperine shows the activity as an enhancer of a …

Curcumin analogs, PGV-1 and CCA-1.1 exhibit anti-migratory effects and suppress MMP9 expression on WiDr cells

F Wulandari, M Kirihata, JY Kato… - The Indonesian …, 2021 - inabj.tjahajabaroe.com
BACKGROUND: Colon cancer is still a crucial concern in the development of
chemotherapeutic drugs due to the drug resistance phenomenon and various side effects to …

A new curcumin analog, CCA-1.1, induces cell death and cell cycle arrest in WiDr colon cancer cells via ROS generation

F Wulandari, M Ikawati, M Kirihata, JY Kato… - Journal of Applied …, 2021 - japsonline.com
Abstract The new Pentagamavunone-1 (PGV-1) derivative, chemoprevention-curcumin
analog 1.1 (CCA-1.1), is described as an improved physicochemical feature with similar …

The integrative bioinformatic analysis deciphers the predicted molecular target gene and pathway from curcumin derivative CCA-1.1 against triple-negative breast …

D Novitasari, RI Jenie, J Kato, E Meiyanto - Journal of the Egyptian …, 2021 - Springer
Background The poor outcomes from triple-negative breast cancer (TNBC) therapy are
mainly because of TNBC cells' heterogeneity, and chemotherapy is the current approach in …

Network pharmacological analysis identifies the curcumin analog CCA-1.1 targeting mitosis regulatory process in HER2-positive breast cancer

D Novitasari, RI Jenie, J Kato… - Indonesian Journal of …, 2023 - journal.ugm.ac.id
Recent studies present that the CCA-1.1 (a curcumin derivative) impedes the proliferation of
breast cancer cells (luminal, HER2-overexpressed, and TNBC cells). Currently, we analyze …

Stability-indicating RP-HPLC method development and validation for simultaneous estimation of bisoprolol fumarate and amlodipine besylate in bulk and in tablet …

RB Gholve, SS Pekamwar… - Journal of Applied …, 2021 - japsonline.com
A novel chromatographic method has been developed with a stability-indicating feature for
simultaneous estimation of bisoprolol fumarate (BSL) and amlodipine besylate (AMD) in …